Glycopyrronium Tosylate Patent Expiration
Glycopyrronium Tosylate is Used for reducing excessive sweating in the underarms in adults and children 9 years of age and older. It was first introduced by Journey Medical Corp
Glycopyrronium Tosylate Patents
Given below is the list of patents protecting Glycopyrronium Tosylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Qbrexza | US10004717 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US10543192 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US10548875 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US8859610 | Crystalline glycopyrrolate tosylate | Feb 28, 2033 | Journey |
| Qbrexza | US9006462 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US9259414 | Glycopyrrolate salts | Feb 28, 2033 | Journey |
| Qbrexza | US9744105 | Topical glycopyrrolate formulations | Jul 18, 2030 | Journey |
| Qbrexza | US8618160 | Topical glycopyrrolate formulations | Dec 10, 2029 | Journey |
| Qbrexza | US10052267 | Topical glycopyrrolate formulations | Oct 17, 2028 | Journey |
| Qbrexza | US6433003 | Method for treating hyperhidrosis in mammals |
Apr 10, 2020
(Expired) | Journey |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Glycopyrronium Tosylate's patents.
Latest Legal Activities on Glycopyrronium Tosylate's Patents
Given below is the list recent legal activities going on the following patents of Glycopyrronium Tosylate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Requirement for information sent under 37 CFR 1.750 | 22 Jan, 2024 | US8618160 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 04 Aug, 2023 | US10548875 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Jul, 2023 | US10543192 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 Apr, 2022 | US8859610 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Feb, 2022 | US10052267 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Dec, 2021 | US10004717 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 07 Sep, 2021 | US8618160 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Sep, 2021 | US8618160 |
| Maintenance Fee Reminder Mailed Critical | 23 Aug, 2021 | US8618160 |
| Second letter to regulating agency to determine regulatory review period | 03 May, 2021 | US8618160 |
Glycopyrronium Tosylate's Family Patents
